Completed studies for:

## All conditions

### Study Results

1. **BI 1199-0211**  
   - Results published  
   - Last Published: 7/22/2026  
   - Study Ended: 7/22/2025  
   - [VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/93877/1199-0211)  
   - Condition: Non-Small Cell Lung Cancer  
   - Publication languages: English

2. **BI 1519-0002**  
   - Results published  
   - Last Published: 6/29/2026  
   - Study Ended: 6/4/2025  
   - [A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/561139/1519-0002)  
   - Condition: Healthy Participants  
   - Publication languages: English

3. **BI 1519-0004**  
   - Results published  
   - Last Published: 6/29/2026  
   - Study Ended: 4/22/2025  
   - [A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/584636/1519-0004)  
   - Condition: Healthy Participants  
   - Publication languages: English

4. **BI 1519-0001**  
   - Results published  
   - Last Published: 6/29/2026  
   - Study Ended: 5/26/2025  
   - [A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/557158/1519-0001)  
   - Condition: Healthy Participants  
   - Publication languages: English

5. **BI 1505-0001**  
   - Results published  
   - Last Published: 6/19/2026  
   - Study Ended: 6/18/2025  
   - [A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/521835/1505-0001)  
   - Condition: Pancreatic Cancer  
   - Publication languages: English

6. **BI 1479-0020**  
   - Results published  
   - Last Published: 6/19/2026  
   - Study Ended: 6/19/2025  
   - [A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/556596/1479-0020)  
   - Condition: Healthy Participants, Hepatic Impairment  
   - Publication languages: English

7. **BI 1447-0012**  
   - Results published  
   - Last Published: 5/21/2026  
   - Study Ended: 5/11/2025  
   - [A Study to Test Different Doses of BI 1569912 in People With Depression](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/527715/1447-0012)  
   - Condition: Depression  
   - Publication languages: English

8. **BI 1447-0001**  
   - Results published  
   - Last Published: 5/20/2026  
   - Study Ended: 9/9/2021  
   - [A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/243095/1447-0001)  
   - Condition: Healthy participants  
   - Publication languages: English

9. **BI 1447-0003**  
   - Results published  
   - Last Published: 5/20/2026  
   - Study Ended: 11/15/2023  
   - [A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/293645/1447-0003)  
   - Condition: Major depressive disorder  
   - Publication languages: English

10. **BI 1447-0004**  
    - Results published  
    - Last Published: 5/20/2026  
    - Study Ended: 10/29/2023  
    - [A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/295457/1447-0004)  
    - Condition: Healthy Volunteers  
    - Publication languages: English

11. **BI 1447-0002**  
    - Results published  
    - Last Published: 5/20/2026  
    - Study Ended: 7/3/2024  
    - [A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/297282/1447-0002)  
    - Condition: Healthy participants  
    - Publication languages: English

12. **BI 1447-0007**  
    - Results published  
    - Last Published: 5/20/2026  
    - Study Ended: 8/19/2024  
    - [A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/535991/1447-0007)  
    - Condition: Healthy Participants  
    - Publication languages: English

13. **BI 1447-0010**  
    - Results published  
    - Last Published: 5/20/2026  
    - Study Ended: 10/2/2024  
    - [A Study in Healthy Men to Test How BI 1569912 is Processed in the Body](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/547683/1447-0010)  
    - Condition: Healthy Participants  
    - Publication languages: English

14. **BI 1199-0393**  
    - Results published  
    - Last Published: 5/12/2026  
    - Study Ended: 5/13/2025  
    - [NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/257935/1199-0393)  
    - Condition:  
    - Publication languages: English

15. **BI 1509-0001**  
    - Results published  
    - Last Published: 5/12/2026  
    - Study Ended: 11/12/2023  
    - [A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/411396/1509-0001)  
    - Condition: Healthy participants  
    - Publication languages: English

16. **BI 1434-0016**  
    - Results published  
    - Last Published: 5/7/2026  
    - Study Ended: 11/8/2023  
    - [A Study in Healthy Men to Test How BI 764198 is Processed in the Body](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/403068/1434-0016)  
    - Condition:  
    - Publication languages: English

17. **BI 1484-0003**  
    - Results published  
    - Last Published: 5/7/2026  
    - Study Ended: 11/9/2023  
    - [A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/424255/1484-0003)  
    - Condition: Healthy participants  
    - Publication languages: English

18. **BI 1245-0276**  
    - Results published  
    - Last Published: 4/29/2026  
    - Study Ended: 4/29/2025  
    - [Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/333496/1245-0276)  
    - Condition:  
    - Publication languages: English

19. **BI 1245-0323**  
    - Results published  
    - Last Published: 4/29/2026  
    - Study Ended: 4/29/2025  
    - [JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/465216/1245-0323)  
    - Condition: Chronic kidney disease  
    - Publication languages: English

20. **BI 1467-0001**  
    - Results published  
    - Last Published: 4/21/2026  
    - Study Ended: 4/9/2025  
    - [A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/401297/1467-0001)  
    - Condition: Solid Tumors  
    - Publication languages: English

21. **BI 1485-0003**  
    - Results published  
    - Last Published: 4/21/2026  
    - Study Ended: 10/23/2023  
    - [A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/413795/1485-0003)  
    - Condition: Healthy participants  
    - Publication languages: English

22. **BI 1160-0309**  
    - Results published  
    - Last Published: 4/21/2026  
    - Study Ended: 4/27/2025  
    - [A Study in the United States That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/415575/1160-0309)  
    - Condition: Venous thromboembolism  
    - Publication languages: English

23. **BI 1199-0545**  
    - Results published  
    - Last Published: 4/21/2026  
    - Study Ended: 4/28/2025  
    - [A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/449976/1199-0545)  
    - Condition: Pulmonary fibrosis  
    - Publication languages: English

24. **BI 1368-0130**  
    - Results published  
    - Last Published: 4/15/2026  
    - Study Ended: 4/10/2025  
    - [A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/457615/1368-0130)  
    - Condition: Hidradenitis suppurativa  
    - Publication languages: English

25. **BI 1199-0378**  
    - Results published  
    - Last Published: 4/10/2026  
    - Study Ended: 8/12/2025  
    - [A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/336943/1199-0378)  
    - Condition: Interstitial lung disease  
    - Publication languages: English

26. **BI 1368-0098**  
    - Results published  
    - Last Published: 4/7/2026  
    - Study Ended: 3/30/2025  
    - [Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/398876/1368-0098)  
    - Condition: Hidradenitis suppurativa  
    - Publication languages: English

27. **BI 1368-0121**  
    - Results published  
    - Last Published: 3/30/2026  
    - Study Ended: 3/30/2025  
    - [Natural History of Netherton Syndrome](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/407336/1368-0121)  
    - Condition: Netherton syndrome  
    - Publication languages: English

28. **BI 1346-0019**  
    - Results published  
    - Last Published: 3/19/2026  
    - Study Ended: 5/27/2019  
    - [A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/194197/1346-0019)  
    - Condition: Healthy participants  
    - Publication languages: English

29. **BI 1346-0035**  
    - Results published  
    - Last Published: 3/19/2026  
    - Study Ended: 5/30/2022  
    - [A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/335075/1346-0035)  
    - Condition:  
    - Publication languages: English

30. **BI 1346-0047**  
    - Results published  
    - Last Published: 3/19/2026  
    - Study Ended: 10/23/2023  
    - [A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/386879/1346-0047)  
    - Condition:  
    - Publication languages: English

31. **BI 1346-0018**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 6/19/2017  
    - [A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253903/1346-0018)  
    - Condition: Healthy participants  
    - Publication languages: English

32. **BI 1346-0016**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 11/11/2018  
    - [A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253929/1346-0016)  
    - Condition: Healthy participants  
    - Publication languages: English

33. **BI 1346-0017**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 1/9/2022  
    - [A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/307137/1346-0017)  
    - Condition: Healthy participants  
    - Publication languages: English

34. **BI 1346-0053**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 12/27/2022  
    - [A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/340979/1346-0053)  
    - Condition:  
    - Publication languages: English

35. **BI 1346-0036**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 10/3/2023  
    - [A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/367995/1346-0036)  
    - Condition:  
    - Publication languages: English

36. **BI 1346-0056**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 5/25/2023  
    - [A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/387937/1346-0056)  
    - Condition:  
    - Publication languages: English

37. **BI 1346-0048**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 12/10/2023  
    - [A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/388501/1346-0048)  
    - Condition:  
    - Publication languages: English

38. **BI 1346-0051**  
    - Results published  
    - Last Published: 3/17/2026  
    - Study Ended: 6/4/2024  
    - [A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/427179/1346-0051)  
    - Condition: Healthy participants  
    - Publication languages: English

39. **BI 1346-0015**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 3/5/2019  
    - [A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/193419/1346-0015)  
    - Condition: Healthy participants  
    - Publication languages: English

40. **BI 1346-0001**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 9/9/2014  
    - [Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253460/1346-0001)  
    - Condition: Healthy participants  
    - Publication languages: English

41. **BI 1346-0002**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 11/15/2015  
    - [Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253865/1346-0002)  
    - Condition: Healthy participants  
    - Publication languages: English

42. **BI 1346-0010**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 2/28/2015  
    - [Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253866/1346-0010)  
    - Condition: Healthy participants  
    - Publication languages: English

43. **BI 1346-0003**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 6/18/2015  
    - [Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253868/1346-0003)  
    - Condition: Healthy participants  
    - Publication languages: English

44. **BI 1346-0004**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 8/5/2015  
    - [Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253869/1346-0004)  
    - Condition: Healthy participants  
    - Publication languages: English

45. **BI 1346-0022**  
    - Results published  
    - Last Published: 3/10/2026  
    - Study Ended: 10/29/2015  
    - [Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/253893/1346-0022)  
    - Condition: Healthy participants  
    - Publication languages: English

46. **BI 1346-0014**  
    - Results published  
    - Last Published: 2/24/2026  
    - Study Ended: 3/17/2025  
    - [A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/331555/1346-0014)  
    - Condition: Schizophrenia  
    - Publication languages: English

47. **BI 1447-0005**  
    - Results published  
    - Last Published: 2/24/2026  
    - Study Ended: 3/27/2025  
    - [A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/465215/1447-0005)  
    - Condition: Depressive disorder  
    - Publication languages: English

48. **BI 1305-0014**  
    - Results published  
    - Last Published: 2/23/2026  
    - Study Ended: 12/16/2024  
    - [A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/339337/1305-0014)  
    - Condition: Idiopathic pulmonary fibrosis  
    - Publication languages: English

49. **BI 1305-0023**  
    - Results published  
    - Last Published: 2/23/2026  
    - Study Ended: 4/13/2025  
    - [A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/339349/1305-0023)  
    - Condition: Progressive Fibrosing Interstitial Lung Disease  
    - Publication languages: English

50. **BI 1368-0104**  
    - Results published  
    - Last Published: 1/29/2026  
    - Study Ended: 7/30/2025  
    - [A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome](https://www.clinicalstudies.boehringer-ingelheim.com/trial/completed/403055/1368-0104)  
    - Condition: Netherton Syndrome  
    - Publication languages: English

---

Load more studies.